QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
Free Trial

IO Biotech (IOBT) Institutional Ownership

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)
Free IOBT Stock Alerts
$1.53
+0.02 (+1.32%)
(As of 04:32 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media

Institutional Ownership Changes (13F Filings) for IO Biotech (NASDAQ:IOBT)

Current
Institutional Ownership
Percentage
54.76%
Number of
Institutional Buyers
(last 12 months)
10
Total
Institutional Inflows
(last 12 months)
$13.66M
Number of
Institutional Sellers
(last 12 months)
3
Total
Institutional Outflows
(last 12 months)
$1.02M
Get IOBT Insider Trade Alerts

Want to know when executives and insiders are buying or selling IO Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

IOBT Institutional Buying and Selling by Quarter

IO Biotech Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/15/2024PFM Health Sciences LP2,341,107$4.40M0.3%+73.0%3.554%
2/15/2024Bridgeway Capital Management LLC145,200$273K0.0%+9.8%0.220%
2/15/2024Citadel Advisors LLC51,867$98K0.0%N/A0.079%
2/13/2024Stonepine Capital Management LLC1,666,037$3.13M1.4%-15.7%2.529%
2/13/2024Armistice Capital LLC1,924,000$3.62M0.0%-10.4%2.920%
11/15/2023Armistice Capital LLC2,148,000$3.03M0.0%N/A3.260%
11/14/2023Stonepine Capital Management LLC1,975,308$2.79M0.9%N/A2.998%
11/14/2023Pivotal bioVenture Partners Investment Advisor LLC864,197$1.22M0.5%N/A1.312%
11/8/2023Vivo Capital LLC6,173,439$8.71M1.1%+104.7%9.371%
8/15/2023Citadel Advisors LLC37,690$74K0.0%-19.5%0.131%
8/14/2023Two Sigma Securities LLC13,020$25K0.0%N/A0.045%
8/11/2023Renaissance Technologies LLC69,100$135K0.0%+12.0%0.240%
7/25/2023Summit Trail Advisors LLC43,744$86K0.0%N/A0.152%
5/12/2023Renaissance Technologies LLC61,700$116K0.0%+155.0%0.214%
2/15/2023Millennium Management LLC20,554$47K0.0%-46.4%0.071%
2/15/2023Morgan Stanley29,060$67K0.0%+31.7%0.101%
2/14/2023RA Capital Management L.P.1,127,260$2.59M0.1%-39.3%3.911%
2/13/2023Renaissance Technologies LLC24,200$56K0.0%+31.4%0.084%
2/10/2023Bank of America Corp DE1,854,185$4.27M0.0%+18,441.9%6.434%
11/15/2022Citadel Advisors LLC42,180$114K0.0%+192.4%0.146%
11/14/2022Renaissance Technologies LLC18,423$50K0.0%N/A0.064%
11/14/2022Psagot Value Holdings Ltd. Israel40,846$111K0.0%N/A0.142%
11/2/2022Victory Capital Management Inc.43,741$119K0.0%N/A0.152%
8/15/2022Millennium Management LLC46,231$216K0.0%-36.4%0.160%
5/17/2022Jane Street Group LLC14,280$76K0.0%N/A0.050%
5/13/2022Ergoteles LLC11,126$59K0.0%N/A0.039%
5/13/2022Vanguard Group Inc.62,234$330K0.0%-69.7%0.216%
2/15/2022Samsara BioCapital LLC1,120,437$7.17M1.4%N/A3.888%
2/15/2022Capital World Investors1,235,000$8.11M0.0%N/A4.286%
2/14/2022Soleus Capital Management L.P.672,734$4.31M0.4%N/A2.335%
2/14/2022Novo Holdings A S3,277,932$20.98M1.0%N/A11.376%
(Data available from 1/1/2016 forward)

IOBT Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of IOBT shares?

During the previous two years, 19 institutional investors and hedge funds held shares of IO Biotech. The most heavily invested institutionals were Vivo Capital LLC ($8.71M), PFM Health Sciences LP ($4.40M), Bank of America Corp DE ($4.27M), Armistice Capital LLC ($3.62M), Stonepine Capital Management LLC ($3.13M), RA Capital Management L.P. ($2.59M), and Pivotal bioVenture Partners Investment Advisor LLC ($1.22M).Learn more on IOBT's institutional investors.

What percentage of IO Biotech stock is owned by institutional investors?

54.76% of IO Biotech stock is owned by institutional investors. Learn more on IOBT's institutional investor holdings.

Which institutional investors have been buying IO Biotech stock?

Of the 16 institutional investors that purchased IO Biotech stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Vivo Capital LLC ($3.16M), Armistice Capital LLC ($2.15M), Stonepine Capital Management LLC ($1.98M), Bank of America Corp DE ($1.84M), PFM Health Sciences LP ($987.65K), Pivotal bioVenture Partners Investment Advisor LLC ($864.20K), and Citadel Advisors LLC ($79.62K).

How much institutional buying is happening at IO Biotech?

Institutional investors have bought a total of 11,312,716 shares in the last 24 months. This purchase volume represents approximately $18.42M in transactions.

Which IO Biotech major shareholders have been selling company stock?

The following institutional investors have sold IO Biotech stock in the last 24 months: RA Capital Management L.P. ($730.50K), Stonepine Capital Management LLC ($309.27K), Armistice Capital LLC ($224K), Vanguard Group Inc. ($142.97K), Millennium Management LLC ($44.27K), and Citadel Advisors LLC ($9.15K).

How much institutional selling is happening at IO Biotech?

Institutional investors have sold a total of 1,460,149 shares in the last 24 months. This volume of shares sold represents approximately $3.62M in transactions.


Related Companies:
This page (NASDAQ:IOBT) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners
Can't believe it's happening again
Manward Press
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
The “Perfect Storm” for Gold
Gold Safe Exchange
Options trading has suddenly become more reliable.
Eagle Publishing
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
The Greatest Bull Market in Crypto History…
Weiss Ratings